Oxford Biomedica and VIB-K.U. Leuven annouce collaborative research project funded by the Motor Neurone Disease Association
05-Jul-2010 -
Oxford BioMedica, VIB and the UK Motor Neurone Disease Association (MND Association) announced the award by MND Association of a research grant to support the further preclinical evaluation of MoNuDin® for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). The grant is ...
amyotrophic lateral sclerosis
clinical trials
gene therapy
+3